Comparison of efficacy and safety for patients with beyond second line treated metastatic colorectal cancer: a network meta-analysis of randomized controlled trials

Cao, MH; Zhou, MY; Zhang, JD

Zhang, JD (corresponding author), China Med Univ, Canc Hosp, Liaoning Canc Hosp & Inst, 44 Xiaoheyan Rd, Shenyang, Liaoning, Peoples R China.

JOURNAL OF CHEMOTHERAPY, 2020; 32 (4): 163

Abstract

Patients with metastatic colorectal cancer (mCRC) beyond second line treatment have a poor prognosis. Regorafenib, TAS-102, fruquintinib, panitumumab ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索